Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
{{output}}
Background: Adeno-associated virus (AAV)-mediated gene therapy has emerged as a promising treatment for hemophilia B. Data on safety and durability from 13 years of follow-up in a cohort of patients who had been successfully trea... ...
